Albert Einstein College of Medicine

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1955-01-01

Employees: 1.9K

Market Cap: -

Website: http://einstein.yu.edu

Clinical Trials

Acupuncture for Chronic Pain

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Procedure: Acupuncture

First Posted Date: 2010-06-23

Last Posted Date: 2012-01-31

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 235

Registration Number: NCT01149317

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States

Sickle Cell Trait and the Risk of Venous Thromboembolism

Terminated

Conditions: Thrombosis

First Posted Date: 2010-06-23

Last Posted Date: 2020-12-17

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 34

Registration Number: NCT01148940

Locations: 🇺🇸
Montefiore Medical Center (Einstein), Bronx, New York, United States

Controlling Hypertension in Diabetes- Feasibility Study

Not Applicable

Completed

Conditions: Type 2 Diabetes
Hypertension
Hyperlipidemia

Interventions: Behavioral: home health/primary care collaboration

First Posted Date: 2010-06-17

Last Posted Date: 2018-12-12

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 56

Registration Number: NCT01145742

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States

Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users

Completed

Conditions: Buprenorphine
HIV Infections
Opioid-related Disorders
HIV
Cognition

First Posted Date: 2010-04-22

Last Posted Date: 2019-04-10

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 40

Registration Number: NCT01108679

Locations: 🇺🇸
Fordham University, Bronx, New York, United States
🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer

Phase 2

Terminated

Conditions: Endometrial Adenocarcinoma
Stage II Uterine Corpus Cancer
Stage IVA Uterine Corpus Cancer
Stage IB Uterine Corpus Cancer
Stage IIIA Uterine Corpus Cancer
Stage IIIC Uterine Corpus Cancer
Stage IVB Uterine Corpus Cancer
Stage IA Uterine Corpus Cancer
Stage IIIB Uterine Corpus Cancer

Interventions: Drug: Paclitaxel
Drug: Carboplatin
Radiation: Internal Radiation Therapy
Radiation: External Beam Radiation Therapy
Other: Laboratory Biomarker Analysis

First Posted Date: 2009-12-30

Last Posted Date: 2023-10-26

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 31

Registration Number: NCT01041027

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States

Central Mechanisms That Regulate Glucose Metabolism in Humans

Phase 4

Active, not recruiting

Conditions: Type 2 Diabetes
Glucose Metabolism Disorders
Glucose, High Blood

Interventions: Drug: Diazoxide
Drug: Placebo

First Posted Date: 2009-12-09

Last Posted Date: 2022-11-16

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 10

Registration Number: NCT01028846

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States

Allergy Immunotherapy for the Reduction of Asthma

Phase 1

Completed

Conditions: Allergy
Asthma
Wheezing

Interventions: Other: Standard of care
Biological: Allergen extracts (subcutaneous injections)

First Posted Date: 2009-12-09

Last Posted Date: 2019-05-28

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 58

Registration Number: NCT01028560

Locations: 🇺🇸
Jacobi Medical Center, Bronx, New York, United States

The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease

Phase 3

Completed

Conditions: Proteinuria
Chronic Renal Insufficiency

Interventions: Other: Placebo
Drug: Vitamin D

First Posted Date: 2009-12-09

Last Posted Date: 2023-08-16

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 74

Registration Number: NCT01029002

Locations: 🇺🇸
Montefiore medical center, Bronx, New York, United States

Smoking Cessation Treatment for Methadone Maintenance Patients

Phase 4

Completed

Conditions: Smoking Cessation
Substance-Related Disorders

Interventions: Drug: Varenicline
Drug: Placebo

First Posted Date: 2009-12-09

Last Posted Date: 2021-05-26

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 112

Registration Number: NCT01027754

Locations: 🇺🇸
Albert Einstein College of Medicine of Yeshiva University, Bronx, New York, United States

Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2

Completed

Conditions: Recurrent Ovarian Carcinoma
Recurrent Primary Peritoneal Carcinoma
Recurrent Fallopian Tube Carcinoma

Interventions: Drug: Carboplatin
Other: Laboratory Biomarker Analysis
Drug: Pemetrexed Disodium

First Posted Date: 2009-10-27

Last Posted Date: 2024-02-28

Lead Sponsor: Albert Einstein College of Medicine

Target Recruit Count: 22

Registration Number: NCT01001910

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States
🇺🇸
Columbia University Medical Center, New York, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy